Skip to main content

International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia

Katona, Cornelius, Livingston, Gill, Cooper, Claudia, Ames, David, Brodaty, Henry, Chiu, Edmond (2007) International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia. International Psychogeriatrics, 19 (3). pp. 345-354. ISSN 1041-6102. (doi:10.1017/S1041610207005145) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:2577)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. (Contact us about this Publication)
Official URL
http://dx.doi.org/10.1017/S1041610207005145

Abstract

Current symptomatic treatments for dementia have only modest efficacy. Assessing meaningful benefits in this variably progressive syndrome is complex and difficult. This consensus statement was generated by an international group representing caregivers, organizations and professionals with expertise in dementia.

To provide meaningful data, economic analyses should use up-to-date, country-specific data. Health economic measures should be incorporated as secondary outcomes in all Phase 3 trials since health systems are concerned with cost-effectiveness as well as clinical outcome. Health utility measures are not, however, validated satisfactorily in dementia, thus calling into question previous health economic analyses. While current drugs appear to reduce the amount of family caregiver time required by PWD, these costs fall in the main on older individuals who often exert little political leverage, rather than on society at large. Traditionally, elderly people have been marginalized in the political process. The growth in the older population across the world, and their potential for increasing political empowerment may lead to a radical re-evaluation of the economics of treatment in dementia.

Item Type: Article
DOI/Identification number: 10.1017/S1041610207005145
Additional information: Consensus Statement
Uncontrolled keywords: dementia; treatment; randomized controlled trials; outcomes; measurement; caregivers; biomarkers; Alzheimer's disease; health economics; culture
Subjects: R Medicine > RC Internal medicine > RC321 Neuroscience. Biological psychiatry. Neuropsychiatry
B Philosophy. Psychology. Religion > BF Psychology
Divisions: Divisions > Division for the Study of Law, Society and Social Justice > School of Social Policy, Sociology and Social Research
Depositing User: Maureen Cook
Date Deposited: 31 Mar 2008 17:51 UTC
Last Modified: 16 Feb 2021 12:14 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/2577 (The current URI for this page, for reference purposes)
  • Depositors only (login required):